| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000042402 |
| Receipt No. | R000048402 |
| Scientific Title | Long-term outcome of Endoscopic gallbladder stenting |
| Date of disclosure of the study information | 2020/11/16 |
| Last modified on | 2020/11/09 (Ver. 1) |
| Basic information | ||
| Public title | Endoscopic gallbladder stenting versus removal of gallbladder drainage, long-term outcome in management of acute cholecystitis in surgical high-risk patients for cholecystectomy | |
| Acronym | Long-term outcome of Endoscopic gallbladder stenting | |
| Scientific Title | Long-term outcome of Endoscopic gallbladder stenting | |
| Scientific Title:Acronym | Long-term outcome of Endoscopic gallbladder stenting | |
| Region |
|
|
| Condition | ||
| Condition | Acute cholecystitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To compare the long-term outcome of long-term EGBS and removal of gallbladder drainage after PTGBD or ETGBD for acute cholecystitis in surgical high-risk patients and to clarify the usefulness of long-term EGBS. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | |
| Assessment | |
| Primary outcomes | To compare the long-term outcome between the EGBS and PT/ENGBD group. |
| Key secondary outcomes | Comparison of the technical success rate, clinical success rate, and early AE rate between the ETGBD and PTGBD. |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients who were considered as surgical high-risk patients and underwent either ETGBD or PTGBD for acute cholecystitis. | |||
| Key exclusion criteria | Prior history of upper gastrointestinal or biliary tract surgery, except for gastrectomy with Billroth I reconstruction; presence of pancreatobiliary malignancies; presence of bile duct stricture, including primary sclerosing cholangitis. | |||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Gifu prefectural general medical center | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 500-8717 | ||||||
| Address | 4-6-1 Noisshiki, Gifu City | ||||||
| TEL | 058-246-1111 | ||||||
| mrak5844@yahoo.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Gifu prefectural general medical center | ||||||
| Division name | Department of Gastroenterology | ||||||
| Zip code | 500-8717 | ||||||
| Address | 4-6-1 Noisshiki, Gifu City | ||||||
| TEL | 058-246-1111 | ||||||
| Homepage URL | |||||||
| mrak5844@yahoo.co.jp | |||||||
| Sponsor | |
| Institute | Gifu prefectural general medical center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Gifu prefectural general medical center |
| Address | 4-6-1 Noisshiki, Gifu City |
| Tel | 058-246-1111 |
| chiken-center.4289@gifu-hp.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 180 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | This was a retrospective cohort study conducted at three tertiary care centers: Gifu Prefectural General Medical Center, Gifu University Hospital, and Gifu Municipal Hospital. The database used for this study included clinical data of all ERCP and PTGBD procedures performed at these three institutions between January 2010 and December 2018.Inclusion criteria were patients who were considered as surgical high-risk patients and underwent either ETGBD or PTGBD for acute cholecystitis. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048402 |